Neurodegenerative/CNS Discovery
Central Nervous System Disorders
Research/Pre-clinicalActive
Key Facts
About Adamed
Adamed Pharma S.A. is a mature, family-owned Polish biopharmaceutical company with nearly 40 years of operational history. It has evolved from a domestic player into an international organization with a diversified commercial portfolio spanning 19 therapeutic areas and a growing proprietary R&D pipeline focused on oncology, CNS disorders, and mRNA vaccines. The company is in a strong commercial phase, evidenced by recent strategic moves like the acquisition of a manufacturing facility in Spain and the launch of a new advanced R&D center, Adamed Discovery, positioning it for further growth in innovative therapeutics.
View full company profileOther Central Nervous System Disorders Drugs
| Drug | Company | Phase |
|---|---|---|
| CNS Pipeline Candidates | Aucta Pharmaceuticals | Not Specified |
| Clinical Trial Support for Pharma | Cognision | N/A (Platform) |
| Undisclosed CNS Program(s) | Biomia | Preclinical |